08.11.2015 • NewsAgricultureagrosciencesDow

Syngenta and Dow in Talks with DuPont on Agribusiness Mergers

The agrochemicals industry is on the brink of a new round of mergers and acquisitions, not seen since 2007, following the collapse of global agriculture prices. According to a report in The Wall Street Journal, citing sources close to the matter, Syngenta is discussing a potential deal with DuPont’s Pioneer division. Separately, DuPont is discussing a deal with Dow’s AgroSciences division. Talks are at an early stage.

Dow announced last month that it was considering options for its agrochemicals subsidiary, focused on creating new synergies in a consolidating agricultural market. Last August, Syngenta rebuffed a third take-over attempt worth $47 billion by US rival Monsanto. Syngenta’s CEO Mike Mack quit on Oct 31 2015.

According to global investment firm Morgan Stanley, a combination of Syngenta and DuPont’s agriculture business would control about 27% of world pesticide sales. Analysts believe such a merger may require Syngenta to divest is US seeds business to smooth antitrust concerns, as DuPont currently controls 35% and 33% of the US corn-seed and soybean markets, respectively.

A merger of DuPont and Dow AgroSciences would control about 17% of the global pesticides market, becoming a close number three behind Syngenta and Bayer, said Morgan Stanley. Dow’s seeds business may also have to be divested if such a merger goes ahead.

The collapse in farm income follows a boom during most of the past decade as crop prices and land values soared as a result of drought and rising demand for corn from the ethanol industry and overseas buyers.

The US Department of Agriculture expects incomes to drop to $58.3 billion this year, down by 36% from 2014’s level of $91.1 billion and registering the largest percentage decline since 1983.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.